GSK has made "substantial" returns from its dual listing of consumer and health products

Release date: 2022-08-31 Hits: 201 Comment: 0

Note: 　　As the world's leading pharmaceutical companies,glaxosmithkline(GSK),according to the official website information o

　　As the world's leading pharmaceutical companies,glaxosmithkline(GSK),according to the official website information on July 18,the company announced its consumer health care companies glaxosmithkline daily health care products(China)co.,LTD.,completed the spin-off from glaxosmithkline,officially became an independent health of the company focus on consumption,was renamed HeLiAng(English name:Haleon).

　　Herrion began trading on the London Stock Exchange(LSE)on July 18.It opened at 330p,giving it a market capitalisation of about 30.5 billion pounds.

　　Herrion CEO Brian Mc-namara presided over the opening ceremony,which kicked off the trading of herrion's shares ahead of their simultaneous listing on the New York Stock Exchange.

　　GSK announced its biggest restructuring in 20 years when it announced its 2021 full-year results on February 9.The new COMPANY will focus on innovative vaccines and drugs.

　　According to herrion's website,the company has a portfolio of globally renowned brands.

　　This time the independent spin-off of Herrion listed,the company's shareholders and domestic partners are profitable"quite a lot".

　　GSK splits its consumer healthcare business into dual listings

Reward

More>Relatednews

0 Related Reviews

Featured

Recommendednews

Ranking

• Liquor short-term dimension valuation repair	• Application of collagen peptide enzymolysis
• What has eaten effective health care product	• Turmeric quercetin will be the golden nutrit
• Why are more and more young people taking he	• Health care product publicity is a conscienc
• TWINLAB health care products are always avai	• Pharmacies selling health care products cont
• "Pit old" health care products fraud without	• "Health care products" routine needs vigilan